BioSig Technologies Supplements Clarification on Recent Schedule 14A Filing. Closing of Merger with Streamex Exchange Corporation Not Affected

Stock Information for Titan Pharmaceuticals Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Titan Pharmaceuticals Inc.

Streamex Corp. (NASDAQ: STEX) Announces Appointment of Kevin Gopaul, Global Financial Executive and ETF Pioneer to Its Board of Directors
Streamex Corp. (NASDAQ: STEX) Announces Launch of $100,000,000 USD GLDY Pre-Sale - A Gold-Backed Yield Generating Stablecoin Offering Institutional Yield on Physical Gold Bullion
Streamex Corp. to Participate at the Cantor Fitzgerald Crypto & AI/Energy Infrastructure Conference on November 10-12, 2025
Streamex Corp. (NASDAQ: STEX) Announces Gold Bullion Purchases & Closing of Initial USD $25,000,000 Tranche of the Previously Announced Financing; All Net Proceeds Deployed into Physical Gold Bullion
Streamex Corp. (NASDAQ: STEX) Announces Nasdaq Approval for Continued Listing on Nasdaq Capital Market & Shareholder Meeting on November 4, 2025
Streamex Corp. (NASDAQ: STEX) Enters Strategic Partnership with Chainlink as Its Official Oracle Provider to Strengthen Tokenization Infrastructure
Streamex Corp. (NASDAQ: STEX) to Participate in the 28th Annual Needham Growth Conference
Streamex Corp. (NASDAQ: STEX) Announces Pre-Sale of Up to $100,000,000 USD for GLDY, a Gold Backed Stablecoin Asset Offering Up to 4.0% Yield

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.